tetraethylammonium has been researched along with sirolimus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, T; Kawamata, T; Maeda, K; Nakai, M; Tanaka, C; Taniguchi, T; Terashima, A; Yasuda, M | 1 |
DePinho, RA; Eisen, AM; Gallo, V; Ghiani, CA; Knutson, PL; McBain, CJ; Yuan, X | 1 |
DuBell, WH; Lederer, WJ; Rogers, TB | 1 |
3 other study(ies) available for tetraethylammonium and sirolimus
Article | Year |
---|---|
Single-channel activity of the Ca2+-dependent K+ channel is modulated by FK506 and rapamycin.
Topics: Animals; Calcineurin Inhibitors; Calcium; Carrier Proteins; DNA-Binding Proteins; Electric Conductivity; Heat-Shock Proteins; Hippocampus; Immunosuppressive Agents; Patch-Clamp Techniques; Polyenes; Potassium Channels; Pyramidal Cells; Rats; Sirolimus; Tacrolimus; Tacrolimus Binding Proteins; Tetraethylammonium | 1998 |
Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Cycle Proteins; Cell Division; Cell Lineage; Cerebellum; Colforsin; Cyclin D; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Deferoxamine; Ion Channel Gating; Isoproterenol; Membrane Potentials; Mice; Microtubule-Associated Proteins; Oligodendroglia; Potassium; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Sirolimus; Stem Cells; Tetraethylammonium; Tumor Suppressor Proteins; Veratridine | 1999 |
K(+) currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin.
Topics: 4-Aminopyridine; Action Potentials; Animals; Calcium; Egtazic Acid; Electric Conductivity; Heart; Immunosuppressive Agents; Mice; Mice, Transgenic; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Sirolimus; Tacrolimus; Tetraethylammonium; Ventricular Function | 2000 |